Chrysanthi Kazeloglou

Chrysanthi Kazeloglou has worked as a Chemist at Bioiatriki Healthcare Group from September 2019 to May 2021. Chrysanthi then joined Therapeia SA Day Care Clinic, Diagnostic Centre as a Chemist from June 2021 to September 2021. Currently, they are working as a Research And Development Analyst at DEMO Pharmaceuticals S.A. since April 2022.

Chrysanthi Kazeloglou completed their Bachelor's degree in Chemistry at the University of Ioannina from 2009 to 2015. Following their undergraduate studies, they pursued a Master of Science (MSc) in Medicinal Chemistry at the same institution from 2015 to 2018. Chrysanthi'smaster's thesis focused on the "Metabolic and Lipid Profile in Breast Cancer: Comparison of cancer stem and non-cancer stem cells."

In addition to their formal education, Chrysanthi has obtained various certifications. Chrysanthi completed the "Learning Data Analytics: 1 Foundations" course at LinkedIn in December 2021. Chrysanthi also completed the "Excel Essential Training (Office 365/Microsoft 365)" and "Learning Data Analytics" courses at LinkedIn in November 2021. Chrysanthi obtained the "Assay Method Validation Mastery" certification from Udemy in October 2021. In the same month, they also completed the "Outlook Essential Training (Office 365/Microsoft 365)" course at LinkedIn.

Furthermore, Chrysanthi attained the "IELTS Academic" certification from the British Council in March 2021. Chrysanthi also engaged in the "Chemicals and Health" program offered by The Johns Hopkins University, although the specific completion month and year are not provided.